Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2009
Response to imatinib plus sirolimus in advanced chordoma
S Stacchiotti, A Marrari, E Tamborini, et al.
International Journal of Oncology
|
May 6, 2011
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer
E Bombardieri, F Crippa, L Maffioli, et al.
European Journal of Nuclear Medicine
|
November 18, 1998
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation
F Crippa, E Seregni, R Agresti, et al.
Nanoscale
|
June 25, 2016
A lock-in-based method to examine the thermal signatures of magnetic nanoparticles in the liquid, solid and aggregated states
C A Monnier, M Lattuada, D Burnand, et al.
Journal of the National Cancer Institute
|
April 20, 2001
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management
M Greco, F Crippa, R Agresti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 27, 1998
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer
F Crippa, R Agresti, E Seregni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2017
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial
A Necchi, S Lo Vullo, P Giannatempo, et al.
European Journal of Nuclear Medicine
|
May 1, 1997
Comparison of three different methods for radiolabelling human activated T lymphocytes
C Botti, D R Negri, E Seregni, et al.
Oral Oncology
|
September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L D Locati, P Bossi, F Perrone, et al.
Investigational New Drugs
|
February 26, 2014
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial
A Necchi, P Giannatempo, L Mariani, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2009
Response to imatinib plus sirolimus in advanced chordoma
S Stacchiotti, A Marrari, E Tamborini, et al.
International Journal of Oncology
|
May 6, 2011
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer
E Bombardieri, F Crippa, L Maffioli, et al.
European Journal of Nuclear Medicine
|
November 18, 1998
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation
F Crippa, E Seregni, R Agresti, et al.
Nanoscale
|
June 25, 2016
A lock-in-based method to examine the thermal signatures of magnetic nanoparticles in the liquid, solid and aggregated states
C A Monnier, M Lattuada, D Burnand, et al.
Journal of the National Cancer Institute
|
April 20, 2001
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management
M Greco, F Crippa, R Agresti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 27, 1998
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer
F Crippa, R Agresti, E Seregni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2017
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial
A Necchi, S Lo Vullo, P Giannatempo, et al.
European Journal of Nuclear Medicine
|
May 1, 1997
Comparison of three different methods for radiolabelling human activated T lymphocytes
C Botti, D R Negri, E Seregni, et al.
Oral Oncology
|
September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L D Locati, P Bossi, F Perrone, et al.
Investigational New Drugs
|
February 26, 2014
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial
A Necchi, P Giannatempo, L Mariani, et al.
Page
of 7